Biogen
BIIB
BIIB
956 hedge funds and large institutions have $32B invested in Biogen in 2023 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 331 increasing their positions, 342 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
956
Holders Change
-43
Holders Change %
-4.3%
% of All Funds
15.24%
Holding in Top 10
14
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-22.22%
% of All Funds
0.22%
New
91
Increased
331
Reduced
342
Closed
118
Calls
$575M
Puts
$517M
Net Calls
+$57.3M
Net Calls Change
+$102M
Top Buyers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$348M |
| 2 |
JPMorgan Chase & Co
New York
|
+$132M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$77.1M |
| 4 |
VanEck Associates
New York
|
+$60.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$53.4M |
